| 000 | 01635 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513231951.0 | ||
| 264 | 0 | _c20010426 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 024 | 7 |
_a10.4049/jimmunol.166.5.2913 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaikh, D I | |
| 245 | 0 | 0 |
_aCutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cMar 2001 |
||
| 300 |
_a2913-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAbatacept |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntigens, CD |
| 650 | 0 | 4 |
_aAntigens, Differentiation _xtherapeutic use |
| 650 | 0 | 4 |
_aAutoantibodies _xbiosynthesis |
| 650 | 0 | 4 | _aCTLA-4 Antigen |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoconjugates |
| 650 | 0 | 4 |
_aImmunoglobulin G _xbiosynthesis |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLupus Nephritis _xdrug therapy |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 |
_aLymphocyte Subsets _xpathology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred NZB |
| 650 | 0 | 4 |
_aProteinuria _xdrug therapy |
| 700 | 1 | _aWofsy, D | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 166 _gno. 5 _gp. 2913-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.166.5.2913 _zAvailable from publisher's website |
| 999 |
_c11145226 _d11145226 |
||